Tyra Biosciences, Inc. (TYRA) Latest Stock News & Headlines
Get the latest Tyra Biosciences, Inc. (TYRA) stock news and headlines to help you in your trading and investing decisions.
Tyra Biosciences, Inc. (TYRA) Stock Price, News, Quote & History ...
Find the latest Tyra Biosciences, Inc. (TYRA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Tyra Biosciences Inc. - MarketWatch
Jan 14, 2025 · TYRA | Complete Tyra Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Tyra Looks to Challenge J&J’s Balversa With Early Data for FGFR3 ...
Oct 25, 2024 · Tyra Biosciences on Thursday unveiled early proof-of-concept data for its investigational and potential first-in-class FGFR3 inhibitor TYRA-300, touting “encouraging” …
Tyra Biosciences Receives IND Clearance from FDA to Proceed …
Oct 28, 2024 · TYRA-300 is a potential first-in-class, investigational, oral, FGFR3-selective inhibitor designed to avoid the toxicities associated with inhibition of FGFR1, FGFR2 and FGFR4.
News Releases - Tyra Bio Investor Relations
Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)
Tyra Biosciences, Inc. (TYRA) Latest Stock News | Seeking Alpha
Get the latest news and real-time alerts from Tyra Biosciences, Inc. (TYRA) stock at Seeking Alpha.
News & Press | Tyra Biosciences
Tyra Biosciences raises $106M in Series B financing to advance novel pipeline of therapies targeting acquired resistance in oncology. Mar 31, 2021.
Tyra Biosciences’ TYRA-300 shows anti-tumor activity in proof-of ...
Oct 24, 2024 · Tyra Biosciences (TYRA) announced clinical proof-of-concept data for TYRA-300 in patients with metastatic urothelial – mUC – cancer from its ongoing SURF301 Phase 1/2 …
Tyra Biosciences, Inc. (TYRA) Stock Price, Quote, News & Analysis ...
A high-level overview of Tyra Biosciences, Inc. (TYRA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.